Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2023 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. The company is PennantPark Investment Corporation, a BDC (business development company) that lends to middle market companies. Management discusses the market environment, their portfolio, deal flow, etc. They talk about their JV (joint venture) with Pantheon, and they talk about their investments in portfolio companies. They mention that they invest in companies and provide loans. They talk about their pipeline and deal flow. They mention that they are seeing an increase in deal flow compared to first half of 2023. They talk about their JV portfolio growing. They talk about their equity co-investments. They talk about the market environment, interest rates, etc. The question is about whether management narrates what their counterparties (i.e., the companies they lend to) are doing and scaling. In this context, the counterparties are the portfolio companies they lend to. But management does not seem to describe the growth, expansion, ramp, adoption, or program build-out of specific portfolio companies. They talk about their portfolio as a whole, credit quality, etc. They mention that they have a diversified portfolio. They talk about their sectors. They do not describe specific customers' trajectories. They talk about their own deal flow and pipeline. They talk about the JV and its growth. They talk about the securitization. They talk about the dividend. The question specifically asks: "does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES?" In this case, the company supplies capital (loans) to portfolio companies.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.